Sector
HealthcareOpen
₹607Prev. Close
₹636Turnover(Lac.)
₹98.75Day's High
₹630Day's Low
₹606.5552 Week's High
₹67052 Week's Low
₹332Book Value
₹73.81Face Value
₹10Mkt Cap (₹ Cr.)
740.83P/E
47.36EPS
13.43Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 12 | 12 | 0.29 | 0.29 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 60.79 | 45.08 | 22.21 | 15.02 |
Net Worth | 72.79 | 57.08 | 22.5 | 15.31 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Revenue | 27.43 | 22.76 | 19.27 |
yoy growth (%) | 20.51 | 18.11 | |
Raw materials | -7.89 | -6.98 | -6.49 |
As % of sales | 28.76 | 30.69 | 33.68 |
Employee costs | -4.68 | -4.51 | -3.45 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Profit before tax | 9.36 | 6.27 | 3.75 |
Depreciation | -0.47 | -0.43 | -0.4 |
Tax paid | -1.92 | -1.26 | -0.76 |
Working capital | 5.04 | 4.98 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 20.51 | 18.11 | |
Op profit growth | 55.74 | 33.7 | |
EBIT growth | 47.96 | 65.21 | |
Net profit growth | 48.53 | 67.3 |
Particulars (Rupees in Crores.) | Mar-2024 |
---|---|
Gross Sales | 56.43 |
Excise Duty | 0 |
Net Sales | 56.43 |
Other Operating Income | 0 |
Other Income | 2.86 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,385 | 90.85 | 91,806.5 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 920.05 | 130.13 | 89,420.8 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 480.8 | 293.17 | 36,298.39 | 68.33 | 0.21 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,202.5 | 89.61 | 32,288.01 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,242 | 59.8 | 25,381.61 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Modi
Whole Time Director & CFO
Namrata Modi
Executive Director
Sai Kalyan Surapaneni
Non Executive Director
Niharika Modi
Independent Non Exe. Director
Nikhil Shrikant Bobade
Independent Non Exe. Director
Sudeep Haralakatte Murthy
Executive Director
Vaibhav Munjal
Independent Non Exe. Director
Pardeep Gandotra
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Prevest Denpro Ltd
Summary
Prevest Denpro Limited is one of the worlds leading dental materials manufacturer. With the continued emphasis on research & development, the Company has been constantly expanding its product range to meet growing needs of dental professionals. The Company was incorporated as Prevest Denpro Limited on May 05, 1999 under the provisions of Companies Act, 1956, with the Registrar of Companies, Jammu & Kashmir with Mr. Atul Modi and Mrs. Namrata Modi as Founders and Promoters of the Company. The Company is primarily involved in the manufacturing and sale of dental materials.The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The product offerings addresses majority of dentists clinical needs for consumable dental materials. The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa. The manufacturing facility is located at Kartholi, Samba (Jammu & Kashmir), comprising of over 27,000 sq. ft. area and has an installed capacity of 200 MT p.a. for manufacturing of dental materials. Further, as per diversification plans, the Company is currently expanding manufacturing unit by setting up anothe
Read More
The Prevest Denpro Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹617.2 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Prevest Denpro Ltd is ₹740.83 Cr. as of 22 Jul ‘24
The PE and PB ratios of Prevest Denpro Ltd is 47.36 and 8.62 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Prevest Denpro Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Prevest Denpro Ltd is ₹332 and ₹670 as of 22 Jul ‘24
Prevest Denpro Ltd's CAGR for 5 Years at N/I%, 3 Years at 49.71%, 1 Year at 13.55%, 6 Month at 42.94%, 3 Month at 57.02% and 1 Month at 23.50%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.